Validation of the BESSt Formula in eyes undergoing phacoemulsification following keratorefractive surgery

ISRCTN ISRCTN34442493
DOI https://doi.org/10.1186/ISRCTN34442493
Secondary identifying numbers N0141187716
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
13/12/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Edmondo Borasio
Scientific

Moorfields Eye Hospital
162 City Road
London
EC1V 2PD
United Kingdom

Email edmondoborasio@gmail.com

Study information

Study designCentrally randomised controlled trial - pilot study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesTo assess the feasibility of a randomised controlled trial to assess the accuracy of a formula (BESSt© formula) recently developed to calculate the power of the lens to implant in the eye during cataract surgery in eyes which have previously undergone laser refractive surgery.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEye Diseases: Cataract
Intervention1. BESSt©
2. Hollday
Intervention typeOther
Primary outcome measure1. Patient recruitment rates
2. Rates of loss to follow up in treatment arm
3. Difference between target and achieved manifest refraction following phaci in the two groups
Secondary outcome measuresProportion of eyes with outcomes within +0.25/0.5/0.75/1/1.50/2.0D from the target refraction using the different formulae
Overall study start date01/08/2006
Completion date01/05/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants30 eyes
Key inclusion criteria1. Any eye undergoing phaco following keratorefractive surgery
2. Any intraocular lens (IOL) model
3. Any type of keratorefractive surgery
4. Patients under the care of Ms Ficker or Mr Stevens
Key exclusion criteria1. Children
2. Corneal scarring or opacity
3. Severe dry eyes or ptosis
4. Complicated phaco, presence of a rhexis tear if IOL is implanted in bag
Date of first enrolment01/08/2006
Date of final enrolment01/05/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Moorfields Eye Hospital
London
EC1V 2PD
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Moorfields Eye Hospital NHS Foundation Trust

No information available

NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2006 Yes No